MDSCs express high levels of IDO in response to IFNγ production and activation in the tumor microenvironment, creating yet another mechanism that drives their immunosuppressive phenotype during tumor progression (Pinton et al., 2016). The gene discussed is IFNG; the disease is neoplasm.